Quantitative Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.96M | Buy |
+9,742
| New | +$9.88M | 0.93% | 22 |
|
|
2025
Q4 | – | Sell |
-19,202
| Closed | -$14.7M | – | 481 |
|
|
2025
Q3 | $14.7M | Sell |
19,202
-5,034
| -21% | -$3.75M | 2.04% | 10 |
|
|
2025
Q2 | $18.9M | Buy |
+24,236
| New | +$18.8M | 2.53% | 7 |
|
|
2025
Q1 | – | Sell |
-26,098
| Closed | -$20.1M | – | 412 |
|
|
2024
Q4 | $20.1M | Buy |
+26,098
| New | +$21.6M | 1.51% | 13 |
|
|
2024
Q1 | – | Sell |
-14,985
| Closed | -$8.73M | – | 318 |
|
|
2023
Q4 | $8.73M | Buy |
+14,985
| New | +$8.75M | 0.5% | 56 |
|
|
2022
Q2 | – | Sell |
-6,076
| Closed | -$1.74M | – | 268 |
|
|
2022
Q1 | $1.74M | Sell |
6,076
-3,790
| -38% | -$975K | 0.19% | 65 |
|
|
2021
Q4 | $2.73M | Buy |
9,866
+3,442
| +54% | +$873K | 0.38% | 58 |
|
|
2021
Q3 | $1.48M | Buy |
+6,424
| New | +$1.59M | 0.13% | 152 |
|
|
2020
Q2 | – | Sell |
-21,579
| Closed | -$2.99M | – | 605 |
|
|
2020
Q1 | $2.99M | Buy |
+21,579
| New | +$2.96M | 0.33% | 73 |
|
|
2019
Q3 | – | Sell |
-73,717
| Closed | -$8.17M | – | 698 |
|
|
2019
Q2 | $8.17M | Buy |
+73,717
| New | +$8.68M | 0.32% | 81 |
|
|
2018
Q3 | – | Sell |
-176,300
| Closed | -$15M | – | 771 |
|
|
2018
Q2 | $15M | Buy |
+176,300
| New | +$14.5M | 0.31% | 65 |
|
|
2018
Q1 | – | Sell |
-124,800
| Closed | -$10.5M | – | 848 |
|
|
2017
Q4 | $10.5M | Buy |
124,800
+1,200
| +1% | +$102K | 0.16% | 153 |
|
|
2017
Q3 | $10.6M | Buy |
123,600
+48,400
| +64% | +$3.97M | 0.12% | 213 |
|
|
2017
Q2 | $6.19M | Buy |
75,200
+8,600
| +13% | +$702K | 0.09% | 276 |
|
|
2017
Q1 | $5.6M | Buy |
+66,600
| New | +$5.33M | 0.09% | 307 |
|
|
2016
Q3 | – | Sell |
-125,500
| Closed | -$9.88M | – | 777 |
|
|
2016
Q2 | $9.88M | Buy |
125,500
+40,100
| +47% | +$3.02M | 0.46% | 48 |
|
|
2016
Q1 | $6.15M | Buy |
85,400
+40,600
| +91% | +$3.07M | 0.3% | 74 |
|
|
2015
Q4 | $3.77M | Buy |
44,800
+17,200
| +62% | +$1.43M | 0.23% | 114 |
|
|
2015
Q3 | $2.31M | Buy |
+27,600
| New | +$2.33M | 0.17% | 151 |
|
|
2015
Q2 | – | Sell |
-53,500
| Closed | -$3.89M | – | 596 |
|
|
2015
Q1 | $3.89M | Buy |
53,500
+8,500
| +19% | +$605K | 0.37% | 51 |
|
|
2014
Q4 | $3.1M | Buy |
45,000
+21,800
| +94% | +$1.47M | 0.48% | 45 |
|
|
2014
Q3 | $1.5M | Sell |
23,200
-33,500
| -59% | -$2.12M | 0.29% | 65 |
|
|
2014
Q2 | $3.52M | Sell |
56,700
-46,600
| -45% | -$2.78M | 0.63% | 26 |
|
|
2014
Q1 | $6.08M | Buy |
103,300
+81,900
| +383% | +$4.57M | 0.29% | 55 |
|
|
2013
Q4 | $1.09M | Sell |
21,400
-9,700
| -31% | -$486K | 0.11% | 184 |
|
|
2013
Q3 | $1.56M | Buy |
31,100
+19,900
| +178% | +$1.04M | 0.14% | 152 |
|
|
2013
Q2 | $550K | Buy |
+11,200
| New | +$609K | 0.1% | 228 |
|
Other funds holding LLY
VCM
VPM
Quantitative Investment Management's LLY Position: Q1 2026 in Review
Quantitative Investment Management opened a new position in Eli Lilly (LLY) in Q1 2026: 9,742 shares worth $8.96M. The stake represents 0.93% of the portfolio and ranks #22 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in LLY as recently as Q3 2025.
Quantitative Investment Management first reported a position in LLY in Q2 2013 and has held it in 27 quarters since. The position peaked at $20.1M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Quantitative Investment Management held 9,742 shares of Eli Lilly worth $8.96M as of Q1 2026.
- Eli Lilly was a new Quantitative Investment Management position in Q1 2026.
- Eli Lilly made up 0.93% of Quantitative Investment Management's portfolio in Q1 2026, its #22 holding.
- Quantitative Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 27 quarters since.
- Quantitative Investment Management's Eli Lilly position peaked at $20.1M in Q4 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.